Ipsen to acquire Memo Therapeutics in deal worth over €700M
Covered by 2 sources · 2 articles
2 outlets - including Yahoo and Seekingalpha - are covering this story.
Covered by
All coverage
Ipsen acquires Memo Therapeutics for up to $800 million
Ipsen to acquire Memo Therapeutics in deal worth over €700M